Novartis Q3: Jimenez talks up Alcon, Gleevec takes generic hammering
October 24, 2017Manufacturing and Production, Sales and Marketing Novartis, biotech, drugs, pharma, pharmaceutical
Novartis released its Q3 financials and, despite Gleevec dipping significantly due to generic competition, still managed to report sales of …
Gilead promotes Alessandro Riva to Senior VP, Hematology and Oncology Therapeutic Area Head
October 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment
Gilead had revealed that it has promoted Dr Alessandro Riva, its Senior Vice President, Hematology and Oncology Therapeutic Area Head, …
AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide
October 24, 2017Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC
New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …
Eisai banks on potential of Biogen’s Alzheimer’s drug
October 24, 2017Manufacturing and Production, Sales and Marketing
Drug developers investigating Alzheimer’s drugs know that they’re taking a gamble; there have been numerous big failures that have caused …
ADC Therapeutics brings in $200 million of financing
October 24, 2017Manufacturing and Production, Sales and Marketing ADC Therapeutics, AstraZeneca, biotech, drugs, pharma, pharmaceutical
ADC Therapeutics has won some serious financial support after its latest financing round managed to net the company $200 million. …
The November 2017 issue of Pharmafocus is now live!
October 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR-T, EMA, NHS, Pharmafocus, Trump, brexit, clinical trial transparency, pharma
The November edition of Pharmafocus is now live and available to read online here!
Recipharm equips Lisbon facility for US and European serialisation
October 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm
Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the …
Securing the cold chain with new solutions
October 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cold chain, manufacturing, supply chain
Ben Hargreaves examines the emerging practical and technological solutions that are aiming to improve patients’ access to medicines in a …
Pharma companies accused of charging NHS twice for treatments
October 23, 2017Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical
A new report published by STOP AIDS and Global Justice Now takes aim at three pharmaceutical companies who have taken …
Public Health England sounds warning against overuse of antibiotics
October 23, 2017Medical Communications, Sales and Marketing Antibiotics, biotech, drugs, pharma, pharmaceutical
Public Health England (PHE) has unveiled the findings from its English surveillance programme for antimicrobial utilisation and resistance report, suggesting …
GSK’s shingles vaccine scores US approval
October 23, 2017Sales and Marketing FDA, GSK, Shingrix, pharma, shingles
GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention …
MSD cuts 1,800 jobs in US operations restructure
October 23, 2017Manufacturing and Production, Sales and Marketing MSD, Merck, job cuts, pharma
MSD has revealed its intention to cut 1,800 sales positions from its workforce in the US. Across the total number, …
$417 million case against J&J thrown out
October 23, 2017Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical, talc
A judge in California has thrown out the lawsuit made by a woman who had alleged that Johnson & Johnson’s …
Report reveals impact of pollution, with 9m deaths worldwide
October 20, 2017Medical Communications biotech, drugs, pharma, pharmaceutical, pollution
A new report published in The Lancet has revealed that all forms of pollution are linked with 9 million deaths …
Top Ten most popular articles on Pharmafile.com this week
October 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Another week gone, and it’s deadline day here at Pharmafocus, meaning you can look forward to our November issue next …
Small number of mutations driving most cancers
October 20, 2017Medical Communications, Research and Development Cancer, biotech, drugs, pharma, pharmaceutical
Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are …
Teva under investigation over illegal rebate offers to Ontario pharmacies
October 20, 2017Medical Communications, Sales and Marketing Teva, fentanyl, opioids, oxycodone
Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to …
Celgene drops $710m drug, shares nosedive 7%
October 20, 2017Medical Communications, Research and Development Celgene, biotech, drugs, pharma, pharmaceutical
Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely …
Worrying number of organ donations blocked by families
October 19, 2017Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical
A report from the BBC has found that 505 registered organ donors had their decision blocked by relatives, over the …
Access to Innovation: Beyond a ‘pharma-only’ approach
October 19, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology
Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
